【レポートの概要（一部）】
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market segmentation & scope
1.2. Information procurement
1.2.1. Purchased database
1.2.2. GVR’s internal database
1.2.3. Secondary sources & third-party perspectives
1.2.4. Primary research
1.3. Information analysis
1.3.1. Data analysis models
1.4. Market formulation & data visualization
1.5. Data validation & publishing
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Antibiotics Market Variables, Trends & Scope
3.1. Market Lineage outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Product Pipeline Analysis, by Stage
3.4. User perspective analysis
3.4.1. Consumer Behavior Analysis
3.4.2. Market Influencer Analysis
3.5. List of Key End-users, by region / by product / by country
3.6. Regulatory Framework
3.6.1. Reimbursement framework
3.6.2. Standards & Compliances
3.7. Market Dynamics
3.7.1. Market Driver Analysis
3.7.2. Development of advanced products
3.7.3. Increasing prevalence of` infectious diseases
3.7.4. Rising collaborative development efforts
3.7.5. Market Restraint Analysis
3.7.6. Uncertain regulatory policies
3.7.7. High R & D cost
3.7.8. Development of resistance against antibiotics
3.7.9. Industry Challenges
3.7.10. Increasing resistance to antibiotics.
3.8. Antibiotics: Market Analysis Tools
3.8.1. Industry Analysis – Porter’s
3.8.1.1. Supplier Power: (Low)
3.8.1.2. Buyer Power: (Moderate)
3.8.1.3. Substitution Threat: (Moderate)
3.8.1.4. Threat from new entrant: (Moderate)
3.8.1.5. Competitive rivalry: (High)
3.8.2. PESTEL Analysis
3.8.2.1. Political Landscape
3.8.2.2. Environmental Landscape
3.8.2.3. Social Landscape
3.8.2.4. Technology Landscape
3.8.2.5. Legal Landscape
3.8.3. Major Deals & Strategic Alliances Analysis
3.8.3.1. Joint Ventures
3.8.3.2. Mergers & Acquisitions
3.8.3.3. Licensing & Partnership
3.8.3.4. Technology Collaborations
3.8.3.5. Strategic Divestments
3.8.4. Market Entry Strategies
Chapter 4. Antibiotics Market: Segment Analysis, By Action Mechanism, 2015 – 2026 (USD Million)
4.1. Definitions & Scope
4.2. Action mechanism market share analysis, 2018 & 2026
4.3. Segment Dashboard
4.4. Global Antibiotics Market, by Action Mechanism, 2015 to 2026
4.5. Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the following
4.5.1. Cell Wall Synthesis Inhibitors
4.5.2. Protein Synthesis Inhibitors
4.5.3. DNA Synthesis Inhibitors
4.5.4. RNA Synthesis Inhibitors
4.5.5. Mycolic Acid Inhibitors
Chapter 5. Antibiotics Market: Segment Analysis, By Drug Class, 2015 – 2026 (USD Million)
5.1. Definitions & Scope
5.2. Action mechanism market share analysis, 2018 & 2026
5.3. Segment Dashboard
5.4. Global Antibiotics Market, by Drug Class, 2015 to 2026
5.5. Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the following
5.5.1. Cephalosporin
5.5.2. Penicillin
5.5.3. Fluoroquinolones
5.5.4. Macrolides
5.5.5. Carbapenem
5.5.6. Aminoglycosides
5.5.7. Sulfonamides
5.5.8. Other
Chapter 6. Antibiotics Market: Regional Market Analysis, 2015 – 2026 (USD Million)
6.1. Definitions & Scope
6.2. Regional market share analysis, 2018 & 2026
6.3. Regional Market Dashboard
6.4. Regional Market Snapshot (Market Size, CAGR, Top Verticals, Key Players, Top Trends)
6.5. Regional Market Share and Leading Players, 2018
6.5.1. North America
6.5.2. Europe
6.5.3. Asia Pacific
6.5.4. Latin America
6.5.5. Middle East & Africa
6.6. SWOT Analysis, by Factor (Political & Legal, Economic And Technological)
6.6.1. North America
6.6.2. Europe
6.6.3. Asia Pacific
6.6.4. Latin America
6.6.5. Middle East & Africa
6.7. Market Size, & Forecasts, and Trend Analysis, 2018 to 2025:
6.8. North America
6.8.1. Market estimates and forecast, by country, 2015 – 2026 (USD Million)
6.8.2. Market estimates and forecast, by action mechanism, 2015 – 2026 (USD Million)
6.8.3. Market estimates and forecast, by drug class, 2015 – 2026 (USD Million)
6.8.4. U.S.
6.8.4.1. Market estimates and forecast, by action mechanism, 2015 – 2026 (USD Million)
6.8.4.2. Market estimates and forecast, by drug class, 2015 – 2026 (USD Million)
6.8.5. Canada
6.8.5.1. Market estimates and forecast, by action mechanism, 2015 – 2026 (USD Million)
6.8.5.2. Market estimates and forecast, by drug class, 2015 – 2026 (USD Million)
6.9. Europe
6.9.1. Market estimates and forecast, by country, 2015 – 2026 (USD Million)
6.9.2. Market estimates and forecast, by action mechanism, 2015 – 2026 (USD Million)
6.9.3. Market estimates and forecast, by drug class, 2015 – 2026 (USD Million)
6.9.4. Germany
6.9.4.1. Market estimates and forecast, by action mechanism, 2015 – 2026 (USD Million)
6.9.4.2. Market estimates and forecast, by drug class, 2015 – 2026 (USD Million)
6.9.5. U.K.
6.9.5.1. Market estimates and forecast, by action mechanism, 2015 – 2026 (USD Million)
6.9.5.2. Market estimates and forecast, by drug class, 2015 – 2026 (USD Million)
6.9.6. France
6.9.6.1. Market estimates and forecast, by action mechanism, 2015 – 2026 (USD Million)
6.9.6.2. Market estimates and forecast, by drug class, 2015 – 2026 (USD Million)
6.9.7. Italy
6.9.7.1. Market estimates and forecast, by action mechanism, 2015 – 2026 (USD Million)
6.9.7.2. Market estimates and forecast, by drug class, 2015 – 2026 (USD Million)
6.9.8. Spain
6.9.8.1. Market estimates and forecast, by action mechanism, 2015 – 2026 (USD Million)
6.9.8.2. Market estimates and forecast, by drug class, 2015 – 2026 (USD Million)
6.10. Asia Pacific
6.10.1. Market estimates and forecast, by country, 2015 – 2026 (USD Million)
6.10.1.1. Market estimates and forecast, by action mechanism, 2015 – 2026 (USD Million)
6.10.1.2. Market estimates and forecast, by drug class, 2015 – 2026 (USD Million)
6.10.2. China
6.10.2.1. Market estimates and forecast, by action mechanism, 2015 – 2026 (USD Million)
6.10.2.2. Market estimates and forecast, by drug class, 2015 – 2026 (USD Million)
6.10.3. Japan
6.10.3.1. Market estimates and forecast, by action mechanism, 2015 – 2026 (USD Million)
6.10.3.2. Market estimates and forecast, by drug class, 2015 – 2026 (USD Million)
6.10.4. India
6.10.4.1. Market estimates and forecast, by action mechanism, 2015 – 2026 (USD Million)
6.10.4.2. Market estimates and forecast, by drug class, 2015 – 2026 (USD Million)
6.10.5. Thailand
6.10.5.1. Market estimates and forecast, by action mechanism, 2015 – 2026 (USD Million)
6.10.5.2. Market estimates and forecast, by drug class, 2015 – 2026 (USD Million)
6.10.6. South Korea
6.10.6.1. Market estimates and forecast, by action mechanism, 2015 – 2026 (USD Million)
6.10.6.2. Market estimates and forecast, by drug class, 2015 – 2026 (USD Million)
6.11. Latin America
6.11.1. Market estimates and forecast, by country, 2015 – 2026 (USD Million)
6.11.2. Market estimates and forecast, by action mechanism, 2015 – 2026 (USD Million)
6.11.3. Market estimates and forecast, by drug class, 2015 – 2026 (USD Million)
6.11.4. Brazil
6.11.4.1. Market estimates and forecast, by action mechanism, 2015 – 2026 (USD Million)
6.11.4.2. Market estimates and forecast, by drug class, 2015 – 2026 (USD Million)
6.11.5. Mexico
6.11.5.1. Market estimates and forecast, by action mechanism, 2015 – 2026 (USD Million)
6.11.5.2. Market estimates and forecast, by drug class, 2015 – 2026 (USD Million)
6.11.6. Argentina
6.11.6.1. Market estimates and forecast, by action mechanism, 2015 – 2026 (USD Million)
6.11.6.2. Market estimates and forecast, by drug class, 2015 – 2026 (USD Million)
6.11.7. Columbia
6.11.7.1. Market estimates and forecast, by action mechanism, 2015 – 2026 (USD Million)
6.11.7.2. Market estimates and forecast, by drug class, 2015 – 2026 (USD Million)
6.12. Middle East and Africa
6.12.1. Market estimates and forecast, by country, 2015 – 2026 (USD Million)
6.12.2. Market estimates and forecast, by action mechanism, 2015 – 2026 (USD Million)
6.12.3. Market estimates and forecast, by drug class, 2015 – 2026 (USD Million)
6.12.4. South Africa
6.12.4.1. Market estimates and forecast, by action mechanism, 2015 – 2026 (USD Million)
6.12.4.2. Market estimates and forecast, by drug class, 2015 – 2026 (USD Million)
6.12.5. Saudi Arabia
6.12.5.1. Market estimates and forecast, by action mechanism, 2015 – 2026 (USD Million)
6.12.5.2. Market estimates and forecast, by drug class, 2015 – 2026 (USD Million)
6.12.6. UAE
6.12.6.1. Market estimates and forecast, by action mechanism, 2015 – 2026 (USD Million)
6.12.6.2. Market estimates and forecast, by drug class, 2015 – 2026 (USD Million)
Chapter 7. Antibiotics Market – Competitive Analysis
7.1. Recent developments & impact analysis, by key market participants
7.2. Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
7.3. Vendor Landscape
7.3.1. List of key distributors and channel partners
7.3.2. Key customers
7.3.3. Key company market share analysis, 2018
7.4. Public Companies
7.4.1. Company market position analysis (Revenue, geographic presence, product portfolio, key serviceable industries, key alliances)
7.4.2. Company Market Share/Ranking, by region
7.4.3. Competitive Dashboard Analysis
7.4.3.1. Market Differentiators
7.4.3.2. Synergy Analysis: Major Deals & Strategic Alliances
7.5. Private Companies
7.5.1. List of key emerging companies’ /technology disruptors/innovators
7.5.2. Funding Outlook (Optional)
7.5.3. Regional network map
7.5.4. Company market position analysis (geographic presence, product portfolio, key alliance, industry experience)
7.6. Supplier Ranking
7.7. Key companies profiled
7.7.1. Pfizer, Inc.
7.7.1.1. Company Overview
7.7.1.2. Financial Performance
7.7.1.3. Product Benchmarking
7.7.1.4. Strategic Initiatives
7.7.2. Janssen Pharmaceuticals.
7.7.2.1. Company Overview
7.7.2.2. Financial Performance
7.7.2.3. Product Benchmarking
7.7.2.4. Strategic Initiatives
7.7.3. Abbott
7.7.3.1. Company Overview
7.7.3.2. Financial Performance
7.7.3.3. Product Benchmarking
7.7.3.4. Strategic Initiatives
7.7.4. GlaxoSmithKline plc.
7.7.4.1. Company Overview
7.7.4.2. Financial Performance
7.7.4.3. Product Benchmarking
7.7.4.4. Strategic Initiatives
7.7.5. Sanofi.
7.7.5.1. Company Overview
7.7.5.2. Financial Performance
7.7.5.3. Product Benchmarking
7.7.5.4. Strategic Initiatives
7.7.6. Novartis AG.
7.7.6.1. Company Overview
7.7.6.2. Financial Performance
7.7.6.3. Product Benchmarking
7.7.6.4. Strategic Initiatives
7.7.7. Bayer AG.
7.7.7.1. Company Overview
7.7.7.2. Financial Performance
7.7.7.3. Product Benchmarking
7.7.7.4. Strategic Initiatives
7.7.8. Bristol-Myers Squibb Company.
7.7.8.1. Company Overview
7.7.8.2. Financial Performance
7.7.8.3. Product Benchmarking
7.7.8.4. Strategic Initiatives
7.7.9. Eli Lilly and Company.
7.7.9.1. Company Overview
7.7.9.2. Financial Performance
7.7.9.3. Product Benchmarking
7.7.9.4. Strategic Initiatives
7.7.10. Astellas Pharma, Inc.
7.7.10.1. Company Overview
7.7.10.2. Financial Performance
7.7.10.3. Product Benchmarking
7.7.10.4. Strategic Initiatives
Chapter 8. KOL Commentary
Chapter 9. Recommendations
【レポート販売概要】
■ タイトル：抗生物質の世界市場：作用機序別（タンパク質、DNA、RNA、細胞壁合成阻害剤）、薬剤クラス別（ペニシリン、セファロスポリン、フルオロキノロン）、セグメント予測■ 英文：Antibiotics Market Size, Share & Trends Analysis Report By Action Mechanism (Protein, DNA, RNA, Cell Wall Synthesis Inhibitors), By Drug Class (Penicillin, Cephalosporins, Fluoroquinolones), And Segment Forecasts, 2019 - 2026
■ 発行日：2019年2月12日
■ 調査会社：Grand View Research
■ 商品コード：GVW903017
■ 調査対象地域：グローバル
- インターヴェンショナル画像下システムの世界市場2017-2021ABSTRACTAbout Interventional Image Guided Systems Medical imaging is the process of creating visual representations of the interior of a body for clinical analysis and medical intervention. It is applied for both diagnostic (screening and diagnosis) and treatment purposes (therapy and surgical purposes). Medical imaging, which is used for treatment purposes, is commonly known as interventional med …
- パウダーコーティング（粉体塗装）の世界市場予測（～2022年）The global powder coatings market is projected to reach USD 13.49 Billion by 2022, at a CAGR of 6.75% from 2017 to 2022. The growing demand for appliances and lightweight automotive has led to an increase in demand for powder coatings. The rising demand from end-use industries in developed and emerging countries has also triggered the growth of the powder coatings market. In 2016, the appliances s …
- オキシ塩化チタンの世界市場Titanium Oxychloride (CAS 92344-13-3) Market Research Report 2014 presents comprehensive data on titanium oxychloride markets globally and regionally (Europe, Asia, North America etc.) The report includes titanium oxychloride description, covers its application areas and related patterns. It overviews titanium oxychloride market, names titanium oxychloride producers and indicates its suppliers. Be …
- 静電気防止フィルムの世界市場2019-2023Global Anti-Static Films Market: About this market Anti-static films are a type of plastic films that provide a decay of static charge to prevent accumulations, which can lead to the discharge or initiation of other nearby electrical events. Technavio’s anti-static films market analysis considers sales from both the segments including rigid and flexible anti-static films. Our analysis also conside …
- 世界の血管塞栓装置市場：製品別、地域別Global Vascular Embolization Devices Market: About this market Technavio’s vascular embolization devices market analysis considers sales from both coiling and non-coiling devices. Our study also finds the sales of vascular embolization devices in Asia, Europe, North America, and ROW. In 2019, the coiling segment had a significant market share, and this trend is expected to continue over the foreca …
- アメリカの乳清タンパク質市場About whey protein Milk consists of two proteins that are casein protein and whey protein. Whey protein is separated from the casein protein in milk. It is also formed as a by-product of cheese making. It is regarded as a complete protein supplement as it is composed of all nine essential amino acids. Whey protein improves the dietary nutrient content and also has a positive effect on the immune s …
- カニューレの世界市場：心臓カニューレ、鼻カニューレ、血管カニューレ、皮膚科カニューレ、関節鏡検査カニューレThe global cannulas market is segmented by product, material, application, end users, and region. On the basis of products, the global cannulas market is segmented into cardiac cannulas, vascular cannulas, nasal cannulas, arthroscopy cannulas, dermatology cannulas and others (floating spinal cannulas, vitreoretinal cannulas, hysterosalpingography cannulas). On the basis of material, the market is …
- 世界のPDM （製品データ管理）ソフトウェア市場About PDM PDM is one of the business functions within collaborative product definition management (cPDM), which is one of the major segments in the Global Product Lifecycle Management (PLM) market. PDM is a software responsible for the creation, management, and publication of product data. PDM helps organize product development by combining documents, technical data, computer-aided design (CAD), a …
- タイル接着剤の世界市場予測Tile adhesive is used to join two substrates and offer excellent chemical resistance, shock & impact resistance, high bond strength, and ultimate flexibility. The tile adhesive works on the basis of cohesive mechanisms and adhesion mechanisms.The tile adhesive market across the world is expected to reach USD 3338.2 million by the end of 2023. The growth of the tile adhesive market can be attribute …
- 世界の遠隔測定（テレメトリー）市場予測及び分析（2014-2019）※当レポートは世界の遠隔測定（テレメトリー）市場の成長要因・制約要因、課題、市場シェア、市場分析、競争環境、関連企業の戦略、 産業別（ヘルスケア、自動車、エネルギー、農業、小売など）・グローバル地域別動向などをまとめました。 The report provides an in-depth analysis of the telemetry market. It provides information about current trends in the market with respect to geographies, countries, segments, technology and current market scenario. It throws light on the current market trends, the drivers and restraints …
- TransGlobe Energy Corporation：石油・ガスの開発・生産動向及びコスト分析- Q3, 2013TransGlobe Energy Corporation Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary TransGlobe Energy Corporation Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an …
- Pressure Relief Devices Market to 2019 – Increasing Focus on Pressure Ulcer Prevention and Quality of Care to Drive GrowthPressure Relief Devices Market to 2019 - Increasing Focus on Pressure Ulcer Prevention and Quality of Care to Drive Growth Summary GBI Research’s report, “Pressure Relief Devices Market to 2019 - Increasing Focus on Pressure Ulcer Prevention and Quality of Care to Drive Growth” looks at the market, competitive landscape, and trends for the four pressure relief devices market segments: mattress ove …
- サブスクリプション・課金管理ソリューションの世界市場予測（～2021年）The subscription and billing management market is estimated to grow from USD 2.90 Billion in 2016 to USD 6.01 Billion by 2021. The market is expected to grow at a Compound Annual Growth Rate (CAGR) of 15.7% because of the increasing demand for integrated high performance order and billing and payment software. The subscription and billing management software has provided many advantages to users i …
- キセノンライトの世界市場2016-2020About the Xenon Lights Market Automotive lighting, including xenon lighting and signaling devices, includes the lights located on the front, sides, and rear of a vehicle. The primary uses of xenon lighting are to ensure visibility for the driver, improve vehicle conspicuity, and indicate the position and presence of other vehicles. In modern cars, xenon lighting is a prominent feature that enhance …
- システム管理ソフトウェアの世界市場About Systems Management Software System management can be defined as the management of distributed systems including computer systems in an enterprise. System management involves multiple tasks such as requirement analysis, purchasing, distributing, configuring, and maintenance of the equipment and software with service updates. In addition, it helps to determine problems and its solutions so tha …
